Skip to content

News & calendar

news: as of 2026-10-08
What the marks mean

Importance is a model-assigned 1–5 on published stories, not a market forecast.

Impact on a scheduled row is a company-prominence tier (High/Medium from graph centrality and size; Low only on curated minor events), not a magnitude forecast.

An earnings date marked confirmed is company-confirmed by Yahoo Finance; estimated is not yet announced. Unmarked rows carry no recorded provenance.

Economic releases are macro and carry no industry, so they stay in every view. A release with no value has not printed yet and says so rather than showing a zero.

Upcoming events across the tracked universe; past events are archived, with outcomes added where available — curated and cited, never fabricated. A past row without one reads “outcome pending”.

A lock-up or index change row adds one line of arithmetic — shares becoming sellable, or shares index funds must buy, as a share of float — read off the prospectus or the index methodology, with both numbers cited in the row. It states the mechanics, not a price move. A lock-up date derived as IPO + 180 days stays estimated until the company states it.

Ahead

scheduled · today and tomorrow · calendar refreshed 2026-10-13

Tue · 13 Oct · today

Wed · 14 Oct

Behind

published · newest first

Fri · 10 Jul

product

20:53
Google News: Intellia Therapeutics

Intellia Therapeutics (NTLA) Is Down 12.1% After Positive Phase 3 Lonvo-z Data And 2027 Launch Plans

Intellia reported positive Phase 3 data for its Lonvo-z therapy with 2027 launch plans, though the stock fell 12.1%.

Markets open original ↗

partnership

20:31
Google News: MDA Space Ltd.

MDA Space to acquire 70% CLS stake, raises $712M to fund the deal

MDA Space agreed to acquire a 70% stake in CLS and raised $712 million to help fund the deal.

Markets open original ↗

regulation

19:04
Google News: Astellas Pharma

Padcev-Keytruda wins broader FDA approval in bladder cancer

Astellas and Pfizer's Padcev-Keytruda combination won broader FDA approval in bladder cancer.

Markets open original ↗

product

17:40
Google News: Astellas Pharma

Astellas Deploys Structure Prediction AI "Boltz-2 NIM" to Democratize and Accelerate Drug Discovery

Astellas deployed the Boltz-2 NIM structure-prediction AI tool to accelerate its drug discovery process.

Markets open original ↗

partnership

16:55
Google News: Dassault Aviation

In Hyderabad, Dassault and Tata are already building the plant to produce two Indian Rafales per month

Dassault and Tata are building a plant in Hyderabad to produce two Indian Rafale jets per month.

Markets open original ↗

The wire

everything that arrived · 7 days